Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arkema Interim / Quarterly Report 2021

May 6, 2021

1117_iss_2021-05-06_f9095f98-cf72-41c0-9d34-fd8215f0cd1a.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Colombes, 6 May 2021

Arkema: First-quarter 2021 results

In a context of clearly improving market conditions, the Group reported strong earnings growth in the first quarter, driven in particular by a rise in volumes of innovative and sustainable Specialty Materials (1), which benefited from their unique positioning and cutting-edge innovation related to global megatrends. Given its confidence in its development dynamic, Arkema is significantly increasing its financial targets for 2021.

  • · Sales of €2.23 billion, up 12.7% versus Q1'20 at constant scope and currency
    • o Significant increase in volumes (+7.7%), in the continuity of the rebound already observed in Q4'20 (+5.2%)
    • o Strong momentum in most of the Group's end markets, and contribution of new developments driven by sustainable innovation
  • EBITDA of €358 million, up sharply by almost 20% (€300 million in Q1'20), and EBITDA margin of 16.1%
    • o Specialty Materials' EBITDA of €306 million, up 19.5%, supported by strong increases in the three segments Adhesive Solutions, Advanced Materials and Coating Solutions
    • o Intermediates' EBITDA of €75 million, up 10.3% (up 18.5% at constant scope)
  • · Adjusted net income up 59% to €159 million, representing €2.08 per share
  • Well controlled net debt, at €2.0 billion (including €700 million in hybrid bonds), representing 1.6x LTM EBITDA
  • Major milestone in Arkema's evolution with the finalization of the divestment of PMMA to Trinseo on 3 May 2021, supplemented by Bostik's recent acquisition of Poliplas
  • 2021 guidance significantly raised, with the Group now targeting around 20% growth in Specially Materials' EBITDA relative to 2020 at constant scope and currency (2) excluding a systemic resumption of the health crisis

Following Arkema's Board of Directors' meeting, held on 5 May 2021 to review the Group's consolidated financial information for the first quarter of 2021, Chairman and CEO Thierry Le Hénaff said:

"The pace of activity accelerated in the first quarter in the context of better economic indicators. Our growth reflects first and foremost the strength of our innovation over the pastion our Specialty Materials in structural growth segments, along with positive momentum in most of our end markets and our balanced geographical footprint. While remaining attentive to the health crisis and to the volatility of the environment, in light of our very good first-quarter results and our development opportunities, the Group is strongly raising its annual targets for Specialty Materials, which represent the essential part of our scope following the divestment of PMMA.

This year marks the start of a new era of growth for Arkema, consistent with the ambitions unveiled at our April 2020 Capital Markets Day. Supported by our teams' strong commitment to the company's strategy, we are accelerating our innovation projects and investments in promising high growth markets driven by sustainable megatrends, such as clean mobility, lightweight materials, 3D printing and energy efficiency."

11 Specially Materials include the following three seaments: Advanced Materials and Coating Solutions 12 With the assumption of a €/\$ exchange rate of 1.2 for 2021, the impact on 2020 EBITDA is estimated at a negative €30 million for Specialty Materials and a negative €10 million for Intermediates

KEY FIGURES FOR FIRST-QUARTER 2021

(In millions of euros) Q1'21 Q1'20 YoY change
Sales 2,226 2,088 +6.6%
EBITDA 358 300 +19.3%
Specialty Materials 306 256 +19.5%
Intermediates 75 68 +10.3%
Corporate -23 -24
EBITDA margin 16.1% 14.4%
Specialty Materials 16.8% 15.2%
Intermediates 19.0% 17.1%
Recurring operating income (REBIT) 223 160 +39.4%
REBIT margin 10.0% 7.7%
Adjusted net income 159 100 +59.0%
Adjusted net income per share (in €) 2.08 1.31 +58.8%
Free cash flow -16 -38
Net debt including hybrid bonds
€1,910m as of 31/12/2020
2,002 2,481

FIRST-QUARTER 2021 BUSINESS PERFORMANCE

Sales rose by 6.6% year on year, to €2,226 million. The 7.7% rise in volumes was driven by overall strong momentum and in particular in the construction and DIY, batteries, electronics, transportation and consumer goods markets. This good performance reflects Arkema's ability to capitalize on rising demand for sustainable, high-performance materials thanks to its offering of innovative products with a high technological content. Certain markets such as packaging and crop nutition nevertheless reported less buoyant growth, due to a high first-quarter 2020 comparison base, while the oil and gas market remained down. The 5.0% positive price effect mainly reflected increased prices in the acrylics chain in the face of higher propylene and initiatives to raise prices in Specialty Materials. The scope effect was a negative 1.7%, with the divestment of Functional Polyolefins only partly offset by the integration of Fixatti and Ideal Work in Adhesive Solutions. The currency effect was a negative 4.4%, primarily owing to the euro's rise against the US dollar. In first-quarter 2021, Specialty Materials sales accounted for 82% of total Group sales (81% in Q1 '20).

Group EBITDA grew by a very strong 19.3% to €358 million, driven by the rise in volumes, the acceleration of new business development, particularly in High Performance Polymers, as well as tight control over fixed costs, and impacted by a close to €15 million unfavorable currency effect. In spite of the strong increase in raw material prices and fransportation costs, all of the Group's segments reported a significant earnings improvement, reflecting the good positioning of the Group's product offering to leverage megatrends, the diversity of its end markets, and its balanced geographical footprint. Specially Materials' EBITDA grew by 19.5% versus last year to €306 million, and Intermediates' EBITDA increased 10.3% to €75 million. In this context, the Group EBITDA margin rose by 170 bps to 16.1%.

As a result, recurring operating income (REBIT) was up almost 40% year on year, to €223 million. This amount includes recurring depreciation of €135 million, down €5 million compared to first-quarter 2020, primarily due to the currency effect. The REBIT margin improved by 230 bps to 10.0%.

Adjusted net income also increased sharply by 59% to €159 million, representing €2.08 per share. Excluding exceptional items, the Group's tax rate amounted to 22% of recurring operating income.

CASH FLOW AND NET DEBT AT MARCH 31, 2021

Arkema reported free cash flow of negative €16 million in first-quarter £38 million in first-quarter 2020). In an environment marked by a rebound in activity, this figure includes an increase in working capital, which is related to the seasonal rise in volumes and raw materials inflation. Working capital remained at a very good level, representing 12.7% of annualized sales at end-March 2021 (16.5% at end-March 2020 and 15.1% at end-March 2019). This reflects, in addition to strict management, inventories that are still below their normative level in the face of good customer demand.

The free cash flow figure also includes the ramp-up of exceptional capital expenditure (€53 million versus €13 million in Q120), relating to the bio-based polyamides project in Singapore and the hydrofluoric acid supply project with Nutrien in the United States. Recuring capital expenditure amounted to €72 million over the quarter (€79 million in Q1 '20).

Including hybrid bonds, net debt was stable at 31 March 2021, at €2.0 billion (€1.9 billion at 31 December 2020), and the net debt (including hybrid bonds) to last-twelve-months EBITDA ratio stood at 1.6x.

FIRST-QUARTER 2021 PERFORMANCE BY SEGMENT

ADHESIVE SOLUTIONS (25% OF TOTAL GROUP SALES)

(In millions of euros) Q1'21 Q1'20 YoY change
Sales દર્શકે 515 +7.8%
EBITDA 86 ਦਰ +24.6%
EBITDA margin 15.5% 13.4%
Recurring operating income (REBIT) 71 54 +31.5%
REBIT margin 12.8% 10.5%

Sales for the Adhesive Solutions segment totaled €555 million, up 7.8% compared to first-quarter 2020, driven mainly by the 8.6% rise in volumes. Momentum remained strong in the construction and DIY markets, particularly in Europe and Asia, in the continuity of second-half 2020, and the segment also benefited from the recovery of industrial markets in high-performance adhesives. Growth in the packaging and hygiene markets was more subdued, owing to a high prior-year comparison base. The 0.4% negative price effect reflects changes in the product mix that overshadowed the impact of higher prices in a context of raw materials inflation. Nevertheless, the price effect is positive sequentially. The positive scope effect of 3.5% corresponds to the integration of Fixatti and Ideal Work, and the currency effect was a negative 3.9%.

At €86 million, EBITDA for the segment rose sharply by almost 25% compared to first-quarter 2020, and the EBITDA margin reached its highest ever level in a quarter at 15.5%, a significant 210-bp increase. This excellent performance notably reflects the momentum in volumes, the impact of our operational excellence initiatives, the repositioning toward higher value-added applications, and the integration of our acquisitions. This helps to reinforce the 14% EBITDA margin target for the year, up by almost 100 bps compared to last year.

ADVANCED MATERIALS (31.5% OF TOTAL GROUP SALES)

(In millions of euros) Q1'21 Q1'20 YoY change
Sales 703 652 +7.8%
EBITDA 142 122 +16.4%
EBITDA margin 20.2% 18.7%
Recurring operating income (REBIT) 81 61 +32.8%
REBIT margin 11.5% 9.4%

At €703 million, sales for the Advanced Materials segment were up almost 8% year on year. Volumes rose by 9.5%, driven primarily by strong growth in High Performance Polymers, and reflect the benefits of innovation and new developments in the batteries, automotive, sports equipment and water filtration markets, while the oil and gas market declined. The rebound observed in fourth-quarter 2020 in several industrial sectors was confirmed, and was accompanied by a rebuilding of inventories by some of our customers. The price effect was a posilive 2.6%, reflecting price increase initiatives in a context of raw materials inflation. The currency effect was a negative 4.3% over the quarter.

In this context of increasing demand for sustainable, high-performance materials, EBITDA for the segment was up 16.4% year on year, to €142 million. The EBITDA margin reached a high level at 20.2% (18.7% in first-quarter 2020).

COATING SOLUTIONS (25.5% OF TOTAL GROUP SALES)

(In millions of euros) Q1'21 Q1'20 YoY change
Sales 567 517 +9.7%
EBITDA 78 65 +20.0%
EBITDA margin 13.8% 12.6%
Recurring operating income (REBIT) 49 36 +36.1%
REBIT margin 8.6% 7.0%

At €567 million, sales for the Coating Solutions segment were up by 9.7% year on year, given a 9.1% positive price which offset higher propylene prices. Volumes rose by 5.8%, driven by a strong dynamic in the decorative paints, 3D printing, industrial coatings, graphic arts and electronics markets, partly offset by product availability femporarily aftected by winter storm United States. The currency effect reduced segment sales by 5.2%.

At €78 million, EBITDA of the Coating Solutions segment was up sharply by 20% on first-quarter 2020, benefiting from the improvement in volumes, price increases in the context of raw materials inflation, and the integration within the acrylics chain of the segment's activities. EBITDA margin was therefore up, at 13.8% (12.6% in firstquarter 2020).

INTERMEDIATES (18% OF TOTAL GROUP SALES)

(In millions of euros) Q1'21 Q1'20 YoY change
Sales 395 397 -0.5%
EBITDA 75 68 +10.3%
EBITDA margin 19.0% 17.1%
Recurring operating income (REBIT) 47 35 +34.3%
REBIT margin 11.9% 8.8%

At €395 million, sales for the Intermediates segment decreased by a slight 0.5% year on year. The 13.6% negative scope effect resulting from the divestment of Functional Polyolefins at 1 June 2020, along with the 4.0% negative currency effect, were more than offset by organic growth of 17.1%. Organic growth was driven by a 10.8% positive price effect and by a 6.3% increase in volumes, mainly reflecting more favorable market conditions in acrylics in Asia, still challenging conditions in Europe and in Asia, and more limited growth in PMMA given the high prior-year comparison base in the context of the pandemic.

In this environment, EBITDA for the segment rose by 10.3% to €75 million (+18.5% at constant scope), and the EBITDA margin came in at 19.0% compared to 17.1% in the prior-year period.

FIRST-QUARTER 2021 HIGHLIGHTS

In order to accelerate the development and production of high value-added engineering adhesives, on 19 January 2021 Arkema announced an investment in CMC (Crackless Monomer Company), a joint venture between Bostik and Taiwanese company Cartell Chemical Co, a leading supplier of cyanoacrylate solutions.

On 1 March 2021, Arkema also finalized its acquisition of Poliplas, a Brazilian leader in hybrid-lechnology sealants and adhesives for the construction market, which had sales of around €10 million in 2020,

Moreover, on 23 February 2021, Arkema announced a new 35% increase in fluoropolymer production capacities in Changshu, China in 2022. This new investment is supported by ever-growing demand in the lithium-ion battery sector, as well as significant opportunities in the water filtration coatings and semiconductor industries.

Lastly, on 23 March 2021, Arkema joined the new CAC40® ESG index on the Paris stock exchange. This new index, which lists the 40 companies in the CAC® Large 60 index that have demonstrated environmental, social and governance (ESG) best promotes the Group's commitments and successes over the past several years for a sustainable economy.

SUBSEQUENT EVENTS

On 3 May 2021, Arkema reached a new milestone in its evolution toward Specialty Materials by finalizing the divestment of its PMMA business to Trinseo. The net proceeds from the sale, which was caried out based on an enterprise value of €1,137 million, will take into account an estimated capital gains tax of around 15% of this amount.

OUTLOOK FOR 2021

The positive market dynamics observed in the first quarter is continuing, supported by strong demand in the construction and DIY markets, and several industrial markets that are important for the Group.

Thanks to its innovation for sustainable development and recent industrial capacity expansions, while being attentive to the market environment, which remains volatile, Arkema considers it is very well positioned to benefit from the strongly rising demand for high-performance materials.

In this environment of robust demand, raw materials inflation should accelerate in the Group will continue its initiatives to increase prices to offset this impact.

In this context, and also in light of its first-quarter financial performance, the Group has raised significantly the Specialty Materials' guidance for 2021. Excluding a systemic resumption of the health crisis,

  • • Specialty Materials' EBITDA is now expected to grow by around 20% in 2021 compared to 2020 at constant scope and currency (3)
  • · Bostik, in line with its 2024 trajectory, confirms its EBITDA margin target of 14% in the year, and Intermediates' EBITDA should at least reach last year's level at constant scope (4) and currency (3).

Finally, Arkema will continue to move ahead with its ambition to become a pure Specialty Materials player by 2024.

Further details concerning the Group's first-quarter 2021 results are provided in the "First quarter 2021 results and outlook" presentation and the Factsheet available on Arkema's website www.finance.arkema.com.

(3) With the assumption of a €/\$ exchange rate of 1.2 for 2021, the impact on 2020 EBITDA is estimated at a negative €30 million for Specialty Materials and a negative €10 million for Intermediates

(4) The combined EBITDA contribution of Functional Polyolefins, divested on 1 June 2020, and of PMMA, divested on 3 May 2021, was close to €135m in 2020 and €45m in 2021 (January - April, PMMA only)

FINANCIAL CALENDAR

20 May 2021 Annual general meeting, held behind closed doors
26 May 2021 Shares trade ex-dividend
29 July 2021 Publication of first-half 2021 results
10 November 2021 Publication of third-quarter 2021 results

Building on its unique set of expertise in materials a world-leading technology portfolio to address ever-growing demand for new and sustainable materials. With the become in 2024 a pure player in Specially Materials, the Group is stuctured into three complementary, resilent and highly innovative segments dedicated to Specialty Materials and Coating Solutions - accounting for some 82% of Group sales, and competitive Internediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, inter alia, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group eported sales of around €8 billion in 2020, and operates in some 55 countries with 20,600 employees worldwide. www.arkema.com

INVESTOR RELATIONS CONTACTS

Béatrice Zilm +33 1 49 00 75 58 [email protected]
Peter Farren +33 1 49 00 73 12 [email protected]
Mathieu Briatta +33 1 49 00 72 07 [email protected]
Caroline Chung +33 1 49 00 74 37 [email protected]
MEDIA CONTACT
Gilles Galinier +33 1 49 00 70 07 [email protected]
Véronique Obrecht +33 1 49 00 88 41 [email protected]

DISCLAIMER

The information disclosed in this press release may contain forward-looking statements with respect to the financial position, results of operations, business and strategy of Arkema.

In the current context, where the Covid-19 pandemic persists across the world, and the situation as well as the magnitude of its impacts on the global economy are highly uncertain, the retained assumptions and forward-looking statements could ultimately prove inaccurate.

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost-reduction projects are implements in the Covid-19 situation, and changes in general economic and financial conditions. Arkema does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect Arkema's financial results is provided in the documents filed with the French Autorité des marchés financiers.

Balance sheet, income statement and cash flow statement data, as well as data relating to the states in shareholders' equity and information by segment included in this press release are extracted financial information at 31 March 2020 reviewed by Arkema's Board of Directors on 5 May 2021. Quarterly financial information is not audited.

Information by segment is presented in accordance with Arkemal reporting system used by management.

Details of the main alternative performance indicators used by the Group are provided in the press release. For the purpose of analyzing its results and defining its targets, the Group also uses EBITDA margin, which corresponds to EBITDA expressed as a percentage of sales, EBITDA equaling recuring income (REBIT) plus recurring depreciation and amortization of tangible and intangible assets, as well as REBIT margin, which corresponds to recuring income (REBIT) expressed as a percentage of sales.

For the purpose of tracking changes in its results, and particularly its sales figures, the following effects (unaudited analyses):

scope effect: the impact of changes in the Group's scope of consolidation, which arse from acquisitions and divestments of entire businesses or as a result of the first-time consolidation of entities. Increases or reductions in capacity are not included in the scope effect;

  • · currency effect: the mechanical impact of consolidating accounts denominated in currencies other than the euro at different exchange rates from one period to another. The currency effect is calculated by applying the foreign exchange rates of the prior period to the figures for the period under review;
  • · price effect: the impact of changes in average selling prices is estimated by comparing the weighted average net unit selling pice of a range of related products in the period under review with their weighted average net unit selling price in the prior period, multiplied, in both cases, by the volumes sold in the period under review;
  • review with the quantities delivered in the prior period, multiplied, in both cases, by the weighted average net unit selling price in the prior period.

HRH

ARKEMA Financial Statements

Consolidated financial information - At the end of March 2021

CONSOLIDATED INCOME STATEMENT

st quarter 2021
1
st quarter 2020
1
(In millions of euros) (non audited) (non audited)
Sales 2,226 2,088
Operating expenses (1,769) (1,672)
Research and development expenses (61) (64)
Selling and administrative expenses (190) (206)
Other income and expenses (24) (14)
Operating income 182 132
Equity in income of affiliates (1) (2)
Financial result (13) (23)
Income taxes (43) (28)
Net income 125 79
Of which non-controlling interests 1 1
Net income - Group share 124 78
Earnings per share (amount in euros) 1.56 1.02
Diluted earnings per share (amount in euros) 1.55 1.02

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

st quarter 2021
1
st quarter 2020
1
(In millions of euros) (non audited) (non audited)
Net income 125 79
Hedging adjustments (15) (7)
Other items - -
Deferred taxes on hedging adjustments and other items - -
Change in translation adjustments 115 17
Other recyclable comprehensive income 100 10
Actuarial gains and losses 61 (24)
Deferred taxes on actuarial gains and losses (13) 8
Other non-recyclable comprehensive income 48 (16)
Total income and expenses recognized directly through equity 148 (6)
Comprehensive income 273 73
Of which: non-controlling interest 2 2
Comprehensive income - Group share 271 71

INFORMATION BY SEGMENT

(non audited)

st quarter 2021
1
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Total sales 555 703 567 395 6 2,226
EBITDA 86 142 78 75 (23) 358
Recurring depreciation and amortization of tangible and intangible
assets
(15) (61) (29) (28) (2) (135)
Recurring operating income (REBIT) 71 81 49 47 (25) 223
Depreciation and amortization related to the revaluation of tangible and
intangible assets as part of the allocation of the purchase price of
businesses (12) (4) (1) - - (17)
Other income and expenses (6) (8) (10) 0 (0) (24)
Operating income 53 69 38 47 (25) 182
Equity in income of affiliates - (1) - (0) - (1)
Intangible assets and property, plant and equipment additions 15 58 11 40 3 127
Of which recurring capital expenditure 15 33 9 12 3 72
st quarter 2020
1
(In millions of euros) Adhesive
Solutions
Advanced
Materials
Coating
Solutions
Intermediates Corporate Total
Total sales 515 652 517 397 7 2,088
EBITDA 69 122 65 68 (24) 300
Recurring depreciation and amortization of tangible and intangible
assets
(15) (61) (29) (33) (2) (140)
Recurring operating income (REBIT) 54 61 36 35 (26) 160
Depreciation and amortization related to the revaluation of tangible and
intangible assets as part of the allocation of the purchase price of
businesses
(8) (4) (2) - - (14)
Other income and expenses (3) (6) (0) (4) (1) (14)
Operating income 43 51 34 31 (27) 132
Equity in income of affiliates - (2) - 0 - (2)
Intangible assets and property, plant and equipment additions 15 38 14 23 2 92
Of which recurring capital expenditure 15 25 14 23 2 79

CONSOLIDATED CASH FLOW STATEMENT

End of March 2021 End of March 2020
(In millions of euros) (non audited) (non audited)
Cash flow - operating activities
Net income 125 79
Depreciation, amortization and impairment of assets 146 156
Other provisions and deferred taxes 12 (7)
(Gains)/losses on sales of long-term assets (2) -
Undistributed affiliate equity earnings 1 2
Change in working capital (137) (132)
Other changes 6 5
Cash flow from operating activities 151 103
Cash flow - investing activities
Intangible assets and property, plant, and equipment additions (127) (92)
Change in fixed asset payables (45) (53)
Acquisitions of operations, net of cash acquired (14) (90)
Increase in long-term loans (8) (8)
Total expenditures (194) (243)
Proceeds from sale of intangible assets and property, plant and equipment 5 1
Change in fixed asset receivables - -
Proceeds from sale of businesses, net of cash transferred - -
Proceeds from sale of unconsolidated investments - -
Repayment of long-term loans 6 6
Total divestitures 11 7
Cash flow from investing activities (183) (236)
Cash flow - financing activities
Issuance (repayment) of shares and other equity - -
Purchase of treasury shares (28) -
Issuance of hybrid bonds - 299
Redemption of hybrid bonds - -
Dividends paid to parent company shareholders
Interest paid to bearers of subordinated perpetual notes
-
(5)
-
-
Dividends paid to non-controlling interests - -
Variation des dividendes à payer - -
Increase in long-term debt 4 2
Decrease in long-term debt (14) (24)
Increase/ decrease in short-term borrowings (4) 1
Cash flow from financing activities (47) 278
Net increase/(decrease) in cash and cash equivalents (79) 145
Effect of exchange rates and changes in scope (14) 5
Cash and cash equivalents at beginning of period 1,587 1,407
Cash and cash equivalents at end of period 1,494 1,557

CONSOLIDATED BALANCE SHEET

31 March 2021 31 December 2020
(In millions of euros) (non audited) (non audited)
ASSETS
Goodwill 1,943 1,933
Other intangible assets, net 1,489 1,433
Property, plant and equipment, net 2,886 2,828
Equity affiliates: investments and loans 30 29
Other investments 57 57
Deferred tax assets 156 159
Other non-current assets 218 209
TOTAL NON-CURRENT ASSETS 6,779 6,648
Inventories 1,006 881
Accounts receivable 1,377 1,131
Other receivables and prepaid expenses 179 163
Income tax receivables 71 70
Other current financial assets 22 40
Cash and cash equivalents 1,494 1,587
Assets held for sale 202 191
TOTAL CURRENT ASSETS 4,351 4,063
TOTAL ASSETS 11,130 10,711
LIABILITIES AND SHAREHOLDERS' EQUITY
Share capital 767 767
Paid-in surplus and retained earnings 4,616 4,458
Treasury shares (34) (6)
Translation adjustments 82 (32)
SHAREHOLDERS' EQUITY - GROUP SHARE 5,431 5,187
Non-controlling interests 50 48
TOTAL SHAREHOLDERS' EQUITY 5,481 5,235
Deferred tax liabilities 346 320
Provisions for pensions and other employee benefits 484 530
Other provisions and non-current liabilities 406 383
Non-current debt 2,663 2,663
TOTAL NON-CURRENT LIABILITIES 3,899 3,896
Accounts payable 1,085 987
Other creditors and accrued liabilities 382 339
Income tax payables 98 69
Other current financial liabilities 19 15
Current debt 133 134
Liabilities related to assets held for sale 33 36
TOTAL CURRENT LIABILITIES 1,750 1,580
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 11,130 10,711

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

(non audited)

Shares issued Shareholders'
(In millions of euros) Number Amount Paid-in
surplus
Hybrid
bonds
Retained
earnings
Translation
adjustments
Number Amount equity - Group
share
Non-controlling
interests
Shareholders'
equity
At January 1, 2021 76,736,476 767 1,272 700 2,486 (32) (59,756) (6) 5,187 48 5,235
Cash dividend - - - - (5) - - - (5) - (5)
Issuance of share capital - - - - - - - - - - -
Purchase of treasury shares - - - - - - - (28) (28) - (28)
Cancellation of purchased treasury shares - - - - - - - - - - -
Grants of treasury shares to employees - - - - - - - - - - -
Sale of treasury shares - - - - - - - - - - -
Share-based payments - - - - 6 - - - 6 - 6
Issuance of hybrid bonds - - - - - - - - - - -
Redemption of hybrid bonds - - - - - - - - - - -
Other - - - - - - - - - - -
Transactions with shareholders - - - - 1 - - (28) (27) - (27)
Net income - - - - 124 - - - 124 1 125
Total income and expense recognized directly through
equity
- - - - 33 114 - - 147 1 148
Comprehensive income - - - - 157 114 - - 271 2 273
At December 31, 2021 76,736,476 767 1,272 700 2,644 82 (59,756) (34) 5,431 50 5,481

ALTERNATIVE PERFORMANCE INDICATORS

To monitor and analyse the financial performance of the Group and its activities, the Group management uses alternative performance indicators. These are financial indicators that are not defined by the IFRS. This note presents a reconciliation of these indicators and the aggregates from the consolidated financial statements under IFRS.

RECURRING OPERATING INCOME (REBIT) AND EBITDA

(In millions of euros) st quarter 2021
1
st quarter 2020
1
OPERATING INCOME 182 132
- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the
allocation of the purchase price of businesses
(17) (14)
- Other income and expenses (24) (14)
RECURRING OPERATING INCOME (REBIT) 223 160
- Recurring depreciation and amortization of tangible and intangible assets (135) (140)
EBITDA 358 300

Details of depreciation and amortization of tangible and intangible assets:

(In millions of euros) st quarter 2021
1
st quarter 2020
1
Depreciation and amortization of tangible and intangible assets (146) (156)
Of which: Recurring depreciation and amortization of tangible and intangible assets (135) (140)
Of which: Depreciation and amortization related to the revaluation of assets as part of the allocation of the
purchase price of businesses
(17) (14)
Of which: Impairment included in other income and expenses 6 (2)

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

(In millions of euros) st quarter 2021
1
st quarter 2020
1
NET INCOME - GROUP SHARE 124 78
- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the
allocation of the purchase price of businesses (17) (14)
- Other income and expenses (24) (14)
- Other income and expenses - Non-controlling interests - -
- Taxes on depreciation and amortization related to the revaluation of assets as part of the allocation of the
purchase price of businesses 4 3
- Taxes on other income and expenses 2 3
- One-time tax effects - -
ADJUSTED NET INCOME 159 100
- Weighted average number of ordinary shares 76,479,782 76,492,807
- Weighted average number of potential ordinary shares 76,736,476 76,658,760
ADJUSTED EARNINGS PER SHARE (in euros) 2.08 1.31
DILUTED ADJUSTED EARNINGS PER SHARE (in euros) 2.07 1.30

RECURRING CAPITAL EXPENDITURE

(In millions of euros) st quarter 2021
1
st quarter 2020
1
INTANGIBLE ASSETS AND PROPERTY, PLANT, AND EQUIPMENT ADDITIONS 127 92
- Exceptional capital expenditure 53 13
- Investments relating to portfolio management operations - -
- Capital expenditure with no impact on net debt 2 0
RECURRING CAPITAL EXPENDITURE 72 79

FREE CASH FLOW AND EBITDA TO CASH CONVERSION RATE

(In millions of euros) st quarter 2021
1
st quarter 2020
1
Cash flow from operating activities 151 103
+ Cash flow from investing activities (183) (236)
NET CASH FLOW (32) (133)
- Net cash flow from portfolio management operations (16) (95)
FREE CASH FLOW (16) (38)

The net cash flow from portfolio management operations corresponds to the impact of acquisition and divestment operations.

NET DEBT

(In millions of euros) End of March 2021 End of December 2020
Non-current debt 2,663 2,663
+ Current debt 133 134
- Cash and cash equivalents 1,494 1,587
NET DEBT 1,302 1,210
+ Hybrid bonds 700 700
NET DEBT AND HYBRID BONDS 2,002 1,910

WORKING CAPITAL

(In millions of euros) End of March 2021 End of December 2020
Inventories 1,006 881
+ Accounts receivable 1,377 1,131
+ Other receivables including income taxes 250 233
+ Other current financial assets 22 40
- Accounts payable 1,085 987
- Other liabilities including income taxes 480 408
- Other current financial liabilities 19 15
WORKING CAPITAL 1,071 875

CAPITAL EMPLOYED

(In millions of euros) End of March 2021 End of December 2020
Goodwill, net 1,943 1,933
+ Intangible assets (excluding goodwill), and property, plant and equipment, net 4,375 4,261
+ Investments in equity affiliates 30 29
+ Other investments and other non-current assets 275 266
+ Working capital 1,071 875
CAPITAL EMPLOYED 7,694 7,364